InvestorsHub Logo
Followers 86
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: biopharm post# 271478

Sunday, 09/04/2016 12:14:12 PM

Sunday, September 04, 2016 12:14:12 PM

Post# of 346002
David Spigel promoted.... read the reasons and think big... Think Bavi and PS Targeting

http://www.ascopost.com/issues/june-25-2016/david-spigel-md-appointed-as-sarah-cannon-chief-scientific-officer/

One is not promoted to CSO at this time on a hunch something works but is promoted because something Big is working

PS Targeting is working and some interesting connections to SCRI

"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News